Apoglyx Company
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
Industry:
PharmTech
Headquarters:
Lund, Skane Lan, Sweden
Zip:
1-10
Founded Date:
2015-01-01
Employees Number:
1-10
Acquisitions Number:
1
Investors Number:
697075
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
pbn@apoglyx.com
Register and Claim Ownership